Defective response of CD4+ T cells to retinoic acid and TGFβ in systemic lupus erythematosus

Arthritis Research and Therapy

Volumn 13, Issue 3, 2011, Pages

  Sobel, Eric S ^a   Brusko, Todd M ^a   Butfiloski, Ed J ^a   Hou, Wei ^b   Li, Shiwu ^a   Cuda, Carla M ^a,c   Abid, Ariana N ^a,d   Reeves, Westley H ^a   Morel, Laurence ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY CD28; RETINOIC ACID; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR PBX1 D; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CD45 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; INTERLEUKIN 7 RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL SELECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; CELL CULTURE; CELL DIVISION; CYTOLOGY; DRUG EFFECT; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION;

ADULT; AGED; ANTIGENS, CD45; ANTINEOPLASTIC AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN; YOUNG ADULT;

EID: 79959548964     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3387     Document Type: Article

References (38)

1. Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 2001, 1:147-153. 10.1038/35100573, 11905822, 11905822.
2. La Cava A. Lupus and T cells. Lupus 2009, 18:196-201. 10.1177/0961203308098191, 19213856.
3. Messner RP, Lindstrom FD, Williams RC. Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus. J Clin Invest 1973, 52:3046-3056. 10.1172/JCI107503, 302579, 4584345.
4. Glinski W, Gershwin ME, Steinberg AD. Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus. J Clin Invest 1976, 57:604-614. 10.1172/JCI108316, 436693, 55418.
5. Rivero SJ, az-Jouanen E, Alarcon-Segovia D. Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum 1978, 21:295-305. 10.1002/art.1780210302, 646828.
6. Tsokos GC, Nambiar MP, Tenbrock K, Juang YT. Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE. Trends Immunol 2003, 24:259-263. 10.1016/S1471-4906(03)00100-5, 12738420.
7. Murashima A, Takasaki Y, Ohgaki M, Hashimoto H, Shirai T, Hirose S. Activated peripheral blood mononuclear cells detected by murine monoclonal antibodies to proliferating cell nuclear antigen in active lupus patients. J Clin Immunol 1990, 10:28-37. 10.1007/BF00917495, 1968905.
8. Dawisha SM, Gmelig-Meyling F, Steinberg AD. Assessment of clinical parameters associated with increased frequency of mutant T cells in patients with systemic lupus erythematosus. Arthritis Rheum 1994, 37:270-277. 10.1002/art.1780370217, 8129782.
9. Scalapino KJ, Tang Q, Bluestone JA, Bonyhadi ML, Daikh DI. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 2006, 177:1451-1459.
10. Horwitz DA. Regulatory T cells in systemic lupus erythematosus: past, present and future. Arthritis Res Ther 2008, 10:227. 10.1186/ar2511, 2656253, 19040771.
11. Bonelli M, Smolen JS, Scheinecker C. Treg and lupus. Ann Rheum Dis 2010, 69:i65-i66. 10.1136/ard.2009.117135, 19995748.
12. La Cava A. The busy life of regulatory T cells in systemic lupus erythematosus. Discov Med 2009, 8:13-17.
13. Yang HX, Zhang W, Zhao LD, Li Y, Zhang FC, Tang FL, He W, Zhang X. Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?. Arthritis Res Ther 2009, 11:R153. 10.1186/ar2829, 2787292, 19821980.
14. Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, Scheinecker C. Phenotypic and functional analysis of CD4+CD25-Foxp3+ T cells in patients with systemic lupus erythematosus. J Immunol 2009, 182:1689-1695.
15. Horwitz D. Identity of mysterious CD4+CD25-Foxp3+ cells in SLE. Arthritis Res Ther 2010, 12:101. 10.1186/ar2894, 2875622, 20122288.
16. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 2007, 204:1765-1774. 10.1084/jem.20070719, 2118687, 17620363.
17. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238. 10.1038/nature04753, 16648838.
18. Wang J, Huizinga TW, Toes RE. De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid. J Immunol 2009, 183:4119-4126. 10.4049/jimmunol.0901065, 19717521.
19. Zhou X, Kong N, Wang J, Fan H, Zou H, Horwitz D, Brand D, Liu Z, Zheng SG. Cutting Edge: All-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. J Immunol 2010, 185:2675-2679. 10.4049/jimmunol.1000598, 3098624, 20679534.
20. Golovina TN, Mikheeva T, Brusko TM, Blazar BR, Bluestone JA, Riley JL. Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells. PLoS ONE 2011, 6:e15868. 10.1371/journal.pone.0015868, 3017077, 21253593.
21. Chen Y, Cuda C, Morel L. Genetic determination of T cell help in loss of tolerance to nuclear antigens. J Immunol 2005, 174:7692-7702.
22. Cuda CM, Zeumer L, Sobel ES, Croker BP, Morel L. Murine lupus susceptibility locus Sle1a requires the expression of two sub-loci to induce inflammatory T cells. Genes Immun 2010, 11:542-553. 10.1038/gene.2010.23, 2958247, 20445563.
23. Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol 2005, 19:685-708. 10.1016/j.berh.2005.03.010, 16150398.
24. Guy M, Borzomato JK, Newall RG, Kalra PA, Price CP. Protein and albumin-to-creatinine ratios in random urines accurately predict 24 h protein and albumin loss in patients with kidney disease. Ann Clin Biochem 2009, 46:468-476. 10.1258/acb.2009.009001, 19729498.
25. Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, Atkinson MA, Bluestone JA. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 2009, 58:652-662. 2646064, 19074986.
26. Roederer M. Interpretation of cellular proliferation data: avoid the panglossian. Cytometry A 2011, 79:95-101.
27. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B, Clayberger C, Soper DM, Ziegler SF, Bluestone JA. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006, 203:1701-1711. 10.1084/jem.20060772, 2118339, 16818678.
28. Scheinecker C, Bonelli M, Smolen JS. Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells. J Autoimmun 2010, 35:269-275. 10.1016/j.jaut.2010.06.018, 20638240.
29. Hill JA, Hall JA, Sun CM, Cai Q, Ghyselinck N, Chambon P, Belkaid Y, Mathis D, Benoist C. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4 + CD44hi cells. Immunity 2008, 29:758-770. 10.1016/j.immuni.2008.09.018, 3140207, 19006694.
30. Zhou X, Bailey-Bucktrout S, Jeker LT, Bluestone JA. Plasticity of CD4(+) FoxP3(+) T cells. Curr Opin Immunol 2009, 21:281-285. 10.1016/j.coi.2009.05.007, 2733784, 19500966.
31. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006, 212:8-27. 10.1111/j.0105-2896.2006.00427.x, 16903903.
32. Shah K, Lee WW, Lee SH, Kim SH, Kang SW, Craft J, Kang I. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther 2010, 12:R53. 10.1186/ar2964, 2888202, 20334681.
33. Murphy KM, Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol 2010, 11:674-680.
34. Barreto M, Ferreira R, Lourenco L, Moraes-Fontes M, Santos E, Alves M, Carvalho C, Martins B, Andreia R, Viana J, Vasconcelos C, Mota-Vieira L, Ferreira C, Demengeot J, Vicente A. Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFb gene variants. BMC Immunol 2009, 10:5. 10.1186/1471-2172-10-5, 2656467, 19173720.
35. Xiao S, Jin H, Korn T, Liu SM, Oukka M, Lim B, Kuchroo VK. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 2008, 181:2277-2284. 2722959, 18684916.
36. DePaolo RW, Abadie V, Tang F, Fehlner-Peach H, Hall JA, Wang W, Marietta EV, Kasarda DD, Waldmann TA, Murray JA, Semrad C, Kupfer SS, Belkaid Y, Guandalini S, Jabri B. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 2011, 471:220-224. 10.1038/nature09849, 21307853.
37. Qin P, Haberbusch JM, Zhang Z, Soprano KJ, Soprano DR. Pre-B cell leukemia transcription factor (PBX) proteins are important mediators for retinoic acid-dependent endodermal and neuronal differentiation of mouse embryonal carcinoma P19 cells. J Biol Chem 2004, 279:16263-16271. 10.1074/jbc.M313938200, 14742427.
38. Chung EY, Liu J, Homma Y, Zhang Y, Brendolan A, Saggese M, Han J, Silverstein R, Selleri L, Ma X. Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1. Immunity 2007, 27:952-964. 10.1016/j.immuni.2007.11.014, 2194654, 18093541.